Carbonic anhydrase inhibitors. Selective inhibition of human tumor-associated isozymes IX and XII and cytosolic isozymes I and II with some substituted-2-mercapto-benzenesulfonamides

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 5, 2006, Pages 563-568

  Saczewski, Franciszek ^a   Innocenti, Alessio ^b   Brzozowski, Zdzisław ^a   Sławiłski, Jarosław ^a   Pomarnacka, Elzbieta ^a   Kornicka, Anita ^a   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CA I; CA II; CA IX; Carbonic anhydrase; Inhibition; Isozymes

Indexed keywords

ACETAZOLAMIDE; ANTINEOPLASTIC AGENT; BENZENESULFONAMIDE DERIVATIVE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; DICLOFENAMIDE; ETHOXZOLAMIDE; INDISULAM; LYASE; METHAZOLAMIDE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; GENE OVEREXPRESSION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

CARBONIC ANHYDRASE INHIBITORS; CYTOSOL; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; NEOPLASMS; SULFONAMIDES;

EID: 33751100628     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600648146     Document Type: Article

References (40)

1. Supuran, CT and Scozzafava, A and Conway, J.(2004) Carbonic anhydrase. Its inhibitors and activators. London: CRC Press.
2. Kivela, AJ and Kivela, J and Saarnio, J and Parkkila, S. (2005) Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours World J Gastroenterol., 11, pp. 155-163.
3. Supuran, CT and Scozzafava, A and Casini, A. (2003) Carbonic anhydrase inhibitors Med Res Rev, 23, pp. 146-189.
4. Supuran, CT and Scozzafava, A. (2000) Carbonic anhydrase inhibitors and their therapeutic potential Exp Opin Ther Patents, 10, pp. 575-600.
5. Supuran, CT.(2004) Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In carbonic anhyrdase. Its inhibitors and activators. (pp. 1-23). CRC Press: London.
6. Pastorekova, S and Parkkila, S and Pastorek, J and Supuran, CT. (2004) Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects J Enz Inhib Med Chem, 19, pp. 199-229.
7. Scozzafava, A and Mastrolorenzo, A and Supuran, CT. (2004) Modulation of carbonic anhydrase activity and its applications in therapy Expert Opin Ther Pat, 14, pp. 667-702.
8. Pastoreková, S and Pastorek, J.(2004) Cancer-related carbonic anhydrase isozymes and their inhibition. In Carbonic anhydrase. Its inhibitors and activators. (pp. 255-281). London: CRC Press.
9. Hentunen, TA and Härkönen, PL and Väänänen, HK.(2000) Carbonic anhydrases in calcified tissues. In The carbonic anhydrases new horizons. (pp. 491-497). Basel, Boston, Berlin: Birkäuser Verlag.
10. Pastorekova, S and Zavadova, Z and Kostal, M and Babusikova, O and Zavada, J. (1992) A novel quasi-viral agent, MaTu, is a two-component system Virology, 187, pp. 620-626.
11. Zavada, J and Zavadova, Z and Pastorekova, S and Ciampor, F and Pastorek, J and Zelnik, V. (1993) Expression of MaTu-MN protein in human tumor cultures and in clinical specimens Int J Cancer, 54, pp. 268-274.
12. Giatromanolaki, A and Koukourakis, MI and Sivridis, E and Pastorek, J and Wykoff, CC and Gatter, KC and Harris, AL. (2001) Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer Cancer Res, 61, pp. 7992-7998.
13. Chia, SK and Wykoff, CC and Watson, PH and Han, C and Leek, RD and Pastorek, J and Gatter, KC and Ratcliffe, P and Harris, AL. (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma J Clin Oncol, 19, pp. 3660-3668.
14. Zavada, J and Zavadova, Z and Pastorek, J and Biesova, Z and Jezek, J and Velek, J. (2000) Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion Br J Cancer, 82, pp. 1808-1813.
15. Stubbs, M and McSheehy, PM and Griffiths, JR and Bashford, CL. (2000) Causes and consequences of tumour acidity and implications for treatment Mol Med Today, 6, pp. 15-19.
16. Xu, L and Fidler, IJ. (2000) Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells Cancer Res., 60, pp. 4610-4616.
17. Fukumura, D and Xu, L and Chen, Y and Gohongi, T and Seed, B and Jain, RK. (2001) Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo Cancer Res., 61, pp. 6020-6024.
18. Kato, Y and Nakayama, Y and Umeda, M and Miyazaki, K. (1992) Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines J Biol Chem, 267, pp. 11424-11430.
19. Reynolds, TY and Rockwell, S and Glazer, PM. (1996) Genetic instability induced by the tumor microenvironment Cancer Res, 56, pp. 5754-5757.
20. Helmlinger, G and Endo, M and Ferrara, N and Hlatky, L and Jain, RK. (2000) Formation of endothelial cell networks Nature, 405, pp. 139-141.
21. Ivanov, SV and Kuzmin, I and Wei, MH and Pack, S and Geil, L and Johnson, BE and Stanbridge, EJ and Lerman, MI. (1998) Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes Proc Natl Acad Sci U.S.A, 95, pp. 12596-12601.
22. Wykoff, CC and Beasley, NJ and Watson, PH and Turner, KJ and Pastorek, J and Sibtain, A and Wilson, GD and Turley, H and Talks, KL and Maxwell, PH and Pugh, CW and Ratcliffe, PJ and Harris, AL. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res, 60, pp. 7075-7083.
23. Svastova, E and Hulikova, A and Rafajova, M and Zat'ovicova, M and Gibadulinova, A and Casini, A and Cecchi, A and Scozzafava, A and Supuran, CT and Pastorek, J and Pastorekova, S. (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett, 577, pp. 439-445.
24. Teicher, BA and Liu, SD and Liu, JT and Holden, SA and Herman, TS. (1993) A carbonic anhydrase inhibitor as a potential modulator of cancer therapies Anticancer Res, 13, pp. 1549-1556.
25. Vukovic, V and Tannock, IF. (1997) Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan Br J Cancer, 75, pp. 1167-1172.
26. Supuran, CT and Casini, A and Scozzafava, A.(2004) Development of carbonic anhydrase inhibitors. In Carbonic anhyrdase. Its inhibitors and activators. (pp. 67-147). London: CRC Press.
27. Pastorekova, S and Casini, A and Scozzafava, A and Vullo, D and Pastorek, J and Supuran, CT. (2004) Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX Bioorg Med Chem Lett, 14, pp. 869-873.
28. Vullo, D and Innocenti, A and Nishimori, I and Pastorek, J and Scozzafava, A and Pastorekova, S and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett, 15, pp. 963-969.
29. Cecchi, A and Hulikova, A and Pastorek, J and Pastorekova, S and Scozzafava, A and Winum, J-Y and Montero, J-L and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis J Med Chem, 48, pp. 4834-4841.
30. Casey, JR and Morgan, PE and Vullo, D and Scozzafava, A and Mastrolorenzo, A and Supuran, CT. (2004) Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX J Med Chem, 47, pp. 2337-2347.
31. Khalifah, RG. (1971) The carbon dioxide hydration activity of carbonic anhydrase. Stop-flow kinetic studies on the native human isoenzymes B and C J Biol Chem, 246, pp. 2561-2573.
32. Brzozowski, Z. (1995) 2-Merccapto-N-(azolyl)benzenesulfonamides I. Synthesis of N-(1,1-dioxo-1,4,2-benzodithiazin-3-yl)guanidines and their transformations into 2-mercapto-N(5-amino-1,2,4-triazol-3-yl)benzenesulfonamide derivatives with potential anti-HIV or anticancer activity Acta Polon Pharm Drug Res 52, pp. 91-101.
33. Brzozowski, Z and Kornicka, A. (1999) Synthesis of some 2-hydroxy-1-[(4-chloro-2-mercaptophenyl)sulfonyl]imidazole derivatives with potential anticancer activity Acta Polon Pharm Drug Res, 56, pp. 135-142.
34. Pomarnacka, E and Kornicka, A. (1998) Synthesis of S,N-substituted 2-mercaptobenzenesulfonamide derivatives with potential pharmacological activity Acta Polon Pharm Drug Res, 55, pp. 297-304.
35. Brzozowski, Z. (1995) 2-Merccapto-N-(azolyl)benzenesulfonamides II. Synthesis, anti-HIV-1 and anticancer activity of some S-substituted
36. Brzozowski, Z. (1998) Synthesis of
37. Neamati, N and Mazumder, A and Sunder, S and Owen, JM and Schultz, RJ and Pommier, Y. (1997) 2-Merccaptobenzenesulfonamides as novel inhibitors of human immunodeficiency virus type 1 integrase and replication Antiviral Chem Chemother, 8, pp. 485-494.
38. Brzozowski, Z and Sławiński, J. (1984) Synthesis of some derivatives of 3-mercapto-1,1-dioxo-1,4,2-benzodithiazine Acta Polon Pharm, 41, pp. 133-139.
39. Brzozowski, Z and Sławinski, J. (1984) Synthesis of some derivatives of 7-carboxy-3-mercapto-1,1-dioxo-1,4,2-benzodithiazine Acta Polon Pharm, 41, pp. 5-13.
40. Brzozowski, Z and Sa̧czewski, F and Sanchez, T and Kuo, Ch-L and Gdaniec, M and Neamati, N. (2004) Synthesis, antiviral and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines Bioorg Med Chem, 12, pp. 3663-3672.